The TRIM21 therapies have been shown to remove toxic tau proteins and reduce symptoms of neurodegeneration in mice.

Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.

Other techniques for targeting tau inside cells, such as anti-sense oligonucleotides (ASOs), have been shown to reduce tau in ...

Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.

Trailhead Biosystems, Inc. (trailbio.com), a biotechnology company creating iPSC-derived human cells at scale for drug discovery and cell therapy, welcomes Josh Snow as Chief Commercial Officer.

To turn TRIM21 into a treatment, McEwan and James, of the Medical Research Council Laboratory of Molecular Biology in ...

The warmer summers and milder winters experienced in Luxembourg over the last few years may sometimes seem like... }} ...

Nona Biosciences collaborates with Umoja Biopharma to advance in vivo CAR-T cell therapies: Cambridge, Massachusetts Saturday, September 14, 2024, 11:00 Hrs [IST] Nona Biosciences ...

Responding to rising mpox cases in Africa, the World Health Organization declared a public health emergency of international ...

Debiopharm, a privately-owned, Swiss-based, biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure ...

While mosquito bites typically don’t cause more damage than an itchy welt, the West Nile virus, a mosquito-borne disease, ...